This Week at FDA: Califf considering diagnostic reform rulemaking, Ashley says goodbye

This Week at FDAThis Week at FDAAPIsBiologicsBiotechnologyCombination ProductsDiagnosticsEuropeMedical DevicesNorth AmericaNutritional/Natural HealthOTCOtherPharmaceuticalsRegulatory Intelligence/Policy